Target intelligence / Profile preview

Potassium two pore domain channel subfamily K member 16 (KCNK16)

Target
KCNK16
Molecular classification
Ion channel, Two pore domain potassium channel (K2P family)
01

Overview

Potassium two pore domain channel subfamily K member 16 (KCNK16, TALK-1) is a voltage-dependent, outward rectifying potassium channel belonging to the two pore domain (K2P) family[1][2][7]. It is mainly activated in alkaline pH and expressed predominantly in the pancreas, particularly in pancreatic islets. The channel combines features of open rectification, preferentially passing outward K+ currents under physiological concentrations, which regulates the electrical excitability of β-cells and therefore insulin secretion[1][6]. KCNK16 orchestrates cytosolic and mitochondrial calcium oscillations, impacting second-phase insulin secretion and overall glucose homeostasis. Genetic variants have been linked to monogenic forms of diabetes (MODY) and other diabetes-related disorders[1][4][6]. The channel can form homo- and heterodimers, and may permeate other monovalent cations such as rubidium (Rb+) and cesium (Cs+)[1]. Its function is tightly linked to hormonal regulation, islet signaling, and metabolic stress adaptation.

Other names
TALK-1TALK1K2p16.12P domain potassium channel Talk-1TWIK-related alkaline pH-activated potassium channel 1pancreatic potassium channel Talk-1potassium channel subfamily K member 16potassium channel two pore domain subfamily K member 16potassium channel, subfamily K, member 16
02

Biological functions

Potassium ion transportRegulation of membrane potentialRegulation of cytosolic calcium oscillations in pancreatic beta cellsModulation of pancreatic hormone secretion (insulin, somatostatin, glucagon)Adaption of beta cells to inflammationGlucose homeostasis
03

Disease associations

Maturity-Onset Diabetes of the Young (MODY)Birk-Barel syndromeImplicated in type 2 diabetesGlucose regulation disorders
04

Safety considerations

Altered channel function could disrupt insulin secretion and glucose homeostasis, increasing risk for diabetesModulation of cytosolic and mitochondrial Ca(2+) may affect beta-cell function

Beyond the preview

Go deeper on Potassium two pore domain channel subfamily K member 16 (KCNK16).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Potassium two pore domain channel subfamily K member 16 (KCNK16).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call